Page 158 - Read Online
P. 158

Page 10 of 11                                 Westwood et al. Mini-invasive Surg 2018;2:38  I  http://dx.doi.org/10.20517/2574-1225.2018.50


               11.  Kapiteijn E, Putter H, Van de Velde C. Impact of the introduction and training of total mesorectal excision on recurrence and survival in
                   rectal cancer in The Netherlands. Br J Surg 2002;89:1142-9.
               12.  Martling AL, Holm T, Rutqvist L, Moran B, Heald R, et al. Effect of a surgical training programme on outcome of rectal cancer in the
                   County of Stockholm. Lancet 2000;356:93-6.
               13.  Wibe A, Møller B, Norstein J, Carlsen E, Wiig JN, et al. A national strategic change in treatment policy for rectal cancer--
                   implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002;45:857-66.
               14.  Morris E, Birch R, West N, Finan P, Forman D, et al. Low abdominoperineal excision rates are associated with high-workload surgeons
                   and lower tumour height. Is further specialization needed? Colorectal Dis 2011;13:755-61.
               15.  Tilney HS, Heriot AG, Purkayastha S, Antoniou A, Aylin P, et al. A national perspective on the decline of abdominoperineal resection
                   for rectal cancer. Ann Surg 2008;247:77-84.
               16.  Morris E, Quirke P, Thomas JD, Fairley L, Cottier B, et al. Unacceptable variation in abdominoperineal excision rates for rectal cancer:
                   time to intervene? Gut 2008;57:1690-7.
               17.  Tilney H, Tekkis P, Heriot A. Report of the national bowel cancer audit project: assessing quality. London: Association of
                   Coloproctology of Great Britain & Ireland; 2006.
               18.  Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol
                   2008;26:303-12.
               19.  How P, Shihab O, Tekkis P, Brown G, Quirke P, et al. A systematic review of cancer related patient outcomes after anterior resection and
                   abdominoperineal excision for rectal cancer in the total mesorectal excision era. Surg Oncol 2011;20:e149-55.
               20.  Zhang XM, Dai JL, Ma SH, Liang JW, Wang Z, et al. Intra-operative perforation: a risk factor for prognosis of low rectal cancer after
                   abdominoperineal resection. Med Oncol 2014;31:964.
               21.  De Nardi P, Summo V, Vignali A, Capretti G. Standard versus extralevator abdominoperineal low rectal cancer excision outcomes: a
                   systematic review and meta-analysis. Ann Surg Oncol 2015;22:2997-3006.
               22.  Holm T, Ljung A, Häggmark T, Jurell G, Lagergren J. Extended abdominoperineal resection with gluteus maximus flap reconstruction
                   of the pelvic floor for rectal cancer. Br J Surg 2007;94:232-8.
               23.  West N, Anderin C, Smith K, Holm T, Quirke P. Multicentre experience with extralevator abdominoperineal excision for low rectal
                   cancer. Br J Surg 2010;97:588-99.
               24.  Stelzner S, Koehler C, Stelzer J, Sims A, Witzigmann H. Extended abdominoperineal excision vs. standard abdominoperineal excision
                   in rectal cancer--a systematic overview. Int J Colorectal Dis 2011;26:1227.
               25.  Quirke P, Thorpe H, Dewberry S. Prospective assessment of the quality of surgery in the MRC CLASICC trial evidence for variation in
                   the plane of surgery in colon cancer, local recurrence and survival. Birmingham, United Kingdom: National Cancer Research Institute
                   conference; 2008.
               26.  Quirke P, Steele R, Monson J, Grieve R, Khanna S, et al. Effect of the plane of surgery achieved on local recurrence in patients with
                   operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet
                   2009;373:821-8.
               27.  Quirke P, Dixon M. The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis
                   1988;3:127-31.
               28.  Eriksen M, Wibe A, Syse A, Haffner J, Wiig J. Inadvertent perforation during rectal cancer resection in Norway. Br J Surg 2004;91:210-6.
               29.  Union for International Cancer Control. TNM Classification of Malignant Tumours. Oxford, UK: Wiley-Blackwell; 2017.
               30.  Bülow S, Christensen IJ, Iversen LH, Harling H; Danish Colorectal Cancer Group. Intra-operative perforation is an important predictor
                   of local recurrence and impaired survival after abdominoperineal resection for rectal cancer. Colorectal Dis 2011;13:1256-64.
               31.  Martijnse IS, Dudink RL, West NP, Wasowicz D, Nieuwenhuijzen GA, et al. Focus on extralevator perineal dissection in supine position
                   for low rectal cancer has led to better quality of surgery and oncologic outcome. Ann Surg Oncol 2012;19:786-93.
               32.  National Institute for Health and Care Excellence. Colorectal cancer: diagnosis and management [CG131]. London; 2014.
               33.  Patel UB, Taylor F, Blomqvist L, George C, Evans H, et al. Magnetic resonance imaging-detected tumor response for locally advanced
                   rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol 2011;29:3753-60.
               34.  Burton S, Brown G, Daniels I, Norman A, Mason B, et al. MRI directed multidisciplinary team preoperative treatment strategy: the way
                   to eliminate positive circumferential margins? Br J Cancer 2006;94:351.
               35.  Jessop J, Beagley C, Heald R. The Pelican Cancer Foundation and The English National MDT-TME Development Programme.
                   Colorectal Dis 2006;8:1-2.
               36.  Taylor C, Sippitt JM, Collins G, McManus C, Richardson A, et al. A pre-post test evaluation of the impact of the PELICAN MDT-TME
                   Development Programme on the working lives of colorectal cancer team members. BMC health Serv Res 2010;10:187.
               37.  Moran B, Holm T, Brannagan G, Chave H, Quirke P, et al. The English national low rectal cancer development programme: key
                   messages and future perspectives. Colorectal Dis 2014;16:173-8.
               38.  Foster J, Gash K, Carter F, West N, Acheson A, et al. Development and evaluation of a cadaveric training curriculum for low rectal
                   cancer surgery in the English LOREC National Development Programme. Colorectal Dis 2014;16.
               39.  Blong J, Chhabra A, James K, Arumagam P, Feldman M. PWE-403 Impact of the lorec programme on low rectal cancer surgery in a
                   UK hospital. Gut 2015;64:A387-8.
               40.  Moran B, Dattani M. “SPECC and SPECULATION”: Is a significant polyp benign or an early colorectal cancer? How do we know and
                   what do we do? Colorectal Dis 2016;18:745-8.
               41.  Heald R, Husband E, Ryall R. The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? Br J Surg 1982;69:613-6.
               42.  Beets-Tan R, Beets G, Vliegen R, Kessels A, Van Boven H, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free
                   resection margin in rectal cancer surgery. Lancet 2001;357:497-504.
   153   154   155   156   157   158   159   160   161   162   163